世界の前臨床CRO治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Preclinical CRO Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4747
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、前臨床CRO治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バイオアナリシス＆DMPK研究、毒性検査、その他）、用途別市場規模（バイオ医薬品企業、政府＆学術機関、医療機器企業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・前臨床CRO治療の市場動向
・企業の競争状況、市場シェア
・前臨床CRO治療の種類別市場規模（バイオアナリシス＆DMPK研究、毒性検査、その他）
・前臨床CRO治療の用途別市場規模（バイオ医薬品企業、政府＆学術機関、医療機器企業）
・前臨床CRO治療の北米市場規模2016-2027（アメリカ、カナダ）
・前臨床CRO治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・前臨床CRO治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・前臨床CRO治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・前臨床CRO治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Charles River Laboratories、Laboratory Corporation of America、Envigo、Eurofins Scientific、PRA Health Science、Wuxi AppTec、Medpace、Pharmaceutical Product Development、Paraxel）
・結論

A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the past, profiting from quickly growing (R&D) spending. Several pharmaceutical companies have lost revenue owing to growing patent expirations thus encouraging several manufacturers to outsource factors of the drug manufacturing method to CROs to decrease costs. Due to this, CROs are witnessing significant development.

Market Analysis and Insights: Global Preclinical CRO Treatment Market
The global Preclinical CRO Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical CRO Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical CRO Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical CRO Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical CRO Treatment market.

Global Preclinical CRO Treatment Scope and Market Size
Preclinical CRO Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical CRO Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Others

Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi AppTec
Medpace
Pharmaceutical Product Development
Paraxel

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical CRO Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Preclinical CRO Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Medical Device Companies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preclinical CRO Treatment Market Perspective (2016-2027)
2.2 Preclinical CRO Treatment Growth Trends by Regions
2.2.1 Preclinical CRO Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preclinical CRO Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Preclinical CRO Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Preclinical CRO Treatment Industry Dynamic
2.3.1 Preclinical CRO Treatment Market Trends
2.3.2 Preclinical CRO Treatment Market Drivers
2.3.3 Preclinical CRO Treatment Market Challenges
2.3.4 Preclinical CRO Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preclinical CRO Treatment Players by Revenue
3.1.1 Global Top Preclinical CRO Treatment Players by Revenue (2016-2021)
3.1.2 Global Preclinical CRO Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Preclinical CRO Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preclinical CRO Treatment Revenue
3.4 Global Preclinical CRO Treatment Market Concentration Ratio
3.4.1 Global Preclinical CRO Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Treatment Revenue in 2020
3.5 Preclinical CRO Treatment Key Players Head office and Area Served
3.6 Key Players Preclinical CRO Treatment Product Solution and Service
3.7 Date of Enter into Preclinical CRO Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical CRO Treatment Breakdown Data by Type
4.1 Global Preclinical CRO Treatment Historic Market Size by Type (2016-2021)
4.2 Global Preclinical CRO Treatment Forecasted Market Size by Type (2022-2027)

5 Preclinical CRO Treatment Breakdown Data by Application
5.1 Global Preclinical CRO Treatment Historic Market Size by Application (2016-2021)
5.2 Global Preclinical CRO Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preclinical CRO Treatment Market Size (2016-2027)
6.2 North America Preclinical CRO Treatment Market Size by Type
6.2.1 North America Preclinical CRO Treatment Market Size by Type (2016-2021)
6.2.2 North America Preclinical CRO Treatment Market Size by Type (2022-2027)
6.2.3 North America Preclinical CRO Treatment Market Size by Type (2016-2027)
6.3 North America Preclinical CRO Treatment Market Size by Application
6.3.1 North America Preclinical CRO Treatment Market Size by Application (2016-2021)
6.3.2 North America Preclinical CRO Treatment Market Size by Application (2022-2027)
6.3.3 North America Preclinical CRO Treatment Market Size by Application (2016-2027)
6.4 North America Preclinical CRO Treatment Market Size by Country
6.4.1 North America Preclinical CRO Treatment Market Size by Country (2016-2021)
6.4.2 North America Preclinical CRO Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Preclinical CRO Treatment Market Size (2016-2027)
7.2 Europe Preclinical CRO Treatment Market Size by Type
7.2.1 Europe Preclinical CRO Treatment Market Size by Type (2016-2021)
7.2.2 Europe Preclinical CRO Treatment Market Size by Type (2022-2027)
7.2.3 Europe Preclinical CRO Treatment Market Size by Type (2016-2027)
7.3 Europe Preclinical CRO Treatment Market Size by Application
7.3.1 Europe Preclinical CRO Treatment Market Size by Application (2016-2021)
7.3.2 Europe Preclinical CRO Treatment Market Size by Application (2022-2027)
7.3.3 Europe Preclinical CRO Treatment Market Size by Application (2016-2027)
7.4 Europe Preclinical CRO Treatment Market Size by Country
7.4.1 Europe Preclinical CRO Treatment Market Size by Country (2016-2021)
7.4.2 Europe Preclinical CRO Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preclinical CRO Treatment Market Size (2016-2027)
8.2 Asia-Pacific Preclinical CRO Treatment Market Size by Type
8.2.1 Asia-Pacific Preclinical CRO Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preclinical CRO Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preclinical CRO Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Preclinical CRO Treatment Market Size by Application
8.3.1 Asia-Pacific Preclinical CRO Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preclinical CRO Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preclinical CRO Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Preclinical CRO Treatment Market Size by Region
8.4.1 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preclinical CRO Treatment Market Size (2016-2027)
9.2 Latin America Preclinical CRO Treatment Market Size by Type
9.2.1 Latin America Preclinical CRO Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Preclinical CRO Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Preclinical CRO Treatment Market Size by Type (2016-2027)
9.3 Latin America Preclinical CRO Treatment Market Size by Application
9.3.1 Latin America Preclinical CRO Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Preclinical CRO Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Preclinical CRO Treatment Market Size by Application (2016-2027)
9.4 Latin America Preclinical CRO Treatment Market Size by Country
9.4.1 Latin America Preclinical CRO Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Preclinical CRO Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preclinical CRO Treatment Market Size (2016-2027)
10.2 Middle East & Africa Preclinical CRO Treatment Market Size by Type
10.2.1 Middle East & Africa Preclinical CRO Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preclinical CRO Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preclinical CRO Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Preclinical CRO Treatment Market Size by Application
10.3.1 Middle East & Africa Preclinical CRO Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preclinical CRO Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preclinical CRO Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Preclinical CRO Treatment Market Size by Country
10.4.1 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Preclinical CRO Treatment Introduction
11.1.4 Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2016-2021)
11.1.5 Charles River Laboratories Recent Development
11.2 Laboratory Corporation of America
11.2.1 Laboratory Corporation of America Company Details
11.2.2 Laboratory Corporation of America Business Overview
11.2.3 Laboratory Corporation of America Preclinical CRO Treatment Introduction
11.2.4 Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2016-2021)
11.2.5 Laboratory Corporation of America Recent Development
11.3 Envigo
11.3.1 Envigo Company Details
11.3.2 Envigo Business Overview
11.3.3 Envigo Preclinical CRO Treatment Introduction
11.3.4 Envigo Revenue in Preclinical CRO Treatment Business (2016-2021)
11.3.5 Envigo Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical CRO Treatment Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2016-2021)
11.4.5 Eurofins Scientific Recent Development
11.5 PRA Health Science
11.5.1 PRA Health Science Company Details
11.5.2 PRA Health Science Business Overview
11.5.3 PRA Health Science Preclinical CRO Treatment Introduction
11.5.4 PRA Health Science Revenue in Preclinical CRO Treatment Business (2016-2021)
11.5.5 PRA Health Science Recent Development
11.6 Wuxi AppTec
11.6.1 Wuxi AppTec Company Details
11.6.2 Wuxi AppTec Business Overview
11.6.3 Wuxi AppTec Preclinical CRO Treatment Introduction
11.6.4 Wuxi AppTec Revenue in Preclinical CRO Treatment Business (2016-2021)
11.6.5 Wuxi AppTec Recent Development
11.7 Medpace
11.7.1 Medpace Company Details
11.7.2 Medpace Business Overview
11.7.3 Medpace Preclinical CRO Treatment Introduction
11.7.4 Medpace Revenue in Preclinical CRO Treatment Business (2016-2021)
11.7.5 Medpace Recent Development
11.8 Pharmaceutical Product Development
11.8.1 Pharmaceutical Product Development Company Details
11.8.2 Pharmaceutical Product Development Business Overview
11.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Introduction
11.8.4 Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2016-2021)
11.8.5 Pharmaceutical Product Development Recent Development
11.9 Paraxel
11.9.1 Paraxel Company Details
11.9.2 Paraxel Business Overview
11.9.3 Paraxel Preclinical CRO Treatment Introduction
11.9.4 Paraxel Revenue in Preclinical CRO Treatment Business (2016-2021)
11.9.5 Paraxel Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preclinical CRO Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bioanalysis and DMPK Studies
Table 3. Key Players of Toxicology Testing
Table 4. Key Players of Others
Table 5. Global Preclinical CRO Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Preclinical CRO Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Preclinical CRO Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Preclinical CRO Treatment Market Share by Regions (2016-2021)
Table 9. Global Preclinical CRO Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Preclinical CRO Treatment Market Share by Regions (2022-2027)
Table 11. Preclinical CRO Treatment Market Trends
Table 12. Preclinical CRO Treatment Market Drivers
Table 13. Preclinical CRO Treatment Market Challenges
Table 14. Preclinical CRO Treatment Market Restraints
Table 15. Global Preclinical CRO Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Preclinical CRO Treatment Market Share by Players (2016-2021)
Table 17. Global Top Preclinical CRO Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical CRO Treatment as of 2020)
Table 18. Ranking of Global Top Preclinical CRO Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Preclinical CRO Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Preclinical CRO Treatment Product Solution and Service
Table 22. Date of Enter into Preclinical CRO Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Preclinical CRO Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Preclinical CRO Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Preclinical CRO Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Preclinical CRO Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Preclinical CRO Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Preclinical CRO Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Preclinical CRO Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Preclinical CRO Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Preclinical CRO Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Preclinical CRO Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Preclinical CRO Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Preclinical CRO Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Preclinical CRO Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Preclinical CRO Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Preclinical CRO Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Preclinical CRO Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Preclinical CRO Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Preclinical CRO Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Preclinical CRO Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Preclinical CRO Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Preclinical CRO Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Preclinical CRO Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Preclinical CRO Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Preclinical CRO Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Preclinical CRO Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Preclinical CRO Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Preclinical CRO Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Preclinical CRO Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Preclinical CRO Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Preclinical CRO Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Preclinical CRO Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Preclinical CRO Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Preclinical CRO Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Preclinical CRO Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Preclinical CRO Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Preclinical CRO Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Preclinical CRO Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Preclinical CRO Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Charles River Laboratories Company Details
Table 63. Charles River Laboratories Business Overview
Table 64. Charles River Laboratories Preclinical CRO Treatment Product
Table 65. Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 66. Charles River Laboratories Recent Development
Table 67. Laboratory Corporation of America Company Details
Table 68. Laboratory Corporation of America Business Overview
Table 69. Laboratory Corporation of America Preclinical CRO Treatment Product
Table 70. Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 71. Laboratory Corporation of America Recent Development
Table 72. Envigo Company Details
Table 73. Envigo Business Overview
Table 74. Envigo Preclinical CRO Treatment Product
Table 75. Envigo Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 76. Envigo Recent Development
Table 77. Eurofins Scientific Company Details
Table 78. Eurofins Scientific Business Overview
Table 79. Eurofins Scientific Preclinical CRO Treatment Product
Table 80. Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 81. Eurofins Scientific Recent Development
Table 82. PRA Health Science Company Details
Table 83. PRA Health Science Business Overview
Table 84. PRA Health Science Preclinical CRO Treatment Product
Table 85. PRA Health Science Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 86. PRA Health Science Recent Development
Table 87. Wuxi AppTec Company Details
Table 88. Wuxi AppTec Business Overview
Table 89. Wuxi AppTec Preclinical CRO Treatment Product
Table 90. Wuxi AppTec Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 91. Wuxi AppTec Recent Development
Table 92. Medpace Company Details
Table 93. Medpace Business Overview
Table 94. Medpace Preclinical CRO Treatment Product
Table 95. Medpace Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 96. Medpace Recent Development
Table 97. Pharmaceutical Product Development Company Details
Table 98. Pharmaceutical Product Development Business Overview
Table 99. Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 100. Pharmaceutical Product Development Recent Development
Table 101. Paraxel Company Details
Table 102. Paraxel Business Overview
Table 103. Paraxel Preclinical CRO Treatment Product
Table 104. Paraxel Revenue in Preclinical CRO Treatment Business (2016-2021) & (US$ Million)
Table 105. Paraxel Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical CRO Treatment Market Share by Type: 2020 VS 2027
Figure 2. Bioanalysis and DMPK Studies Features
Figure 3. Toxicology Testing Features
Figure 4. Others Features
Figure 5. Global Preclinical CRO Treatment Market Share by Application: 2020 VS 2027
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Government and Academic Institutes Case Studies
Figure 8. Medical Device Companies Case Studies
Figure 9. Preclinical CRO Treatment Report Years Considered
Figure 10. Global Preclinical CRO Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Preclinical CRO Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Preclinical CRO Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Preclinical CRO Treatment Market Share by Regions (2022-2027)
Figure 14. Global Preclinical CRO Treatment Market Share by Players in 2020
Figure 15. Global Top Preclinical CRO Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical CRO Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Preclinical CRO Treatment Revenue in 2020
Figure 17. Global Preclinical CRO Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Preclinical CRO Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Preclinical CRO Treatment Market Share by Type (2016-2027)
Figure 21. North America Preclinical CRO Treatment Market Share by Application (2016-2027)
Figure 22. North America Preclinical CRO Treatment Market Share by Country (2016-2027)
Figure 23. United States Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Preclinical CRO Treatment Market Share by Type (2016-2027)
Figure 27. Europe Preclinical CRO Treatment Market Share by Application (2016-2027)
Figure 28. Europe Preclinical CRO Treatment Market Share by Country (2016-2027)
Figure 29. Germany Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Preclinical CRO Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Preclinical CRO Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Preclinical CRO Treatment Market Share by Region (2016-2027)
Figure 39. China Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Preclinical CRO Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Preclinical CRO Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Preclinical CRO Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Preclinical CRO Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Preclinical CRO Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Preclinical CRO Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Preclinical CRO Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Charles River Laboratories Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 59. Laboratory Corporation of America Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 60. Envigo Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 61. Eurofins Scientific Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 62. PRA Health Science Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 63. Wuxi AppTec Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 64. Medpace Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 65. Pharmaceutical Product Development Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 66. Paraxel Revenue Growth Rate in Preclinical CRO Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の前臨床X線画像市場規模・現状・予測（2021年-2027年）

Global Preclinical X-ray Imaging Market Size, Status and Forecast 2021-2027
QYR2104Z4753 2021年4月 98Pages
QYResearch社発行の本調査資料では、前臨床X線画像のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市場規模（北米、アメリ...

世界の前臨床画像（In-VIVO）市場規模・現状・予測（2021年-2027年）

Global Preclinical Imaging (In-VIVO) Market Size, Status and Forecast 2021-2027
QYR2104Z4748 2021年4月 97Pages
QYResearch社発行の本調査資料では、前臨床画像（In-VIVO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬）、用途別市場規模（腫瘍、心臓＆血管、神経、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の陽電子放出断層撮影（PET）市場規模・現状・予測（2021年-2027年）

Global Preclinical Positron Emission Tomography (PET) Market Size, Status and Forecast 2021-2027
QYR2104Z4751 2021年4月 92Pages
QYResearch社発行の本調査資料では、陽電子放出断層撮影（PET）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市場規模...

世界の前臨床脳画像市場規模・現状・予測（2021年-2027年）

Global Preclinical Brain Imaging Market Size, Status and Forecast 2021-2027
QYR2104Z4746 2021年4月 96Pages
QYResearch社発行の本調査資料では、前臨床脳画像のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コンピュータ断層撮影（CT）、ポジトロン放出断層撮影（PET）、磁気共鳴画像法（MRI）、単一光子放射型コンピュータ断層撮影（SPECT）、...

世界の磁気共鳴画像（MRI）市場規模・現状・予測（2021年-2027年）

Global Preclinical Magnetic Resonance Imaging (MRI) Market Size, Status and Forecast 2021-2027
QYR2104Z4750 2021年4月 96Pages
QYResearch社発行の本調査資料では、磁気共鳴画像（MRI）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市場規模（北米...

世界の単一光子放射断層撮影（SPECT）市場規模・現状・予測（2021年-2027年）

Global Preclinical Single Photon Emission Computed Tomography (SPECT) Market Size, Status and Forecast 2021-2027
QYR2104Z4752 2021年4月 92Pages
QYResearch社発行の本調査資料では、単一光子放射断層撮影（SPECT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市...

世界の前臨床CRO治療市場 2021：企業別、地域別、種類・用途別

Global Preclinical CRO Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z11436 2021年4月 109Pages
当調査資料では、前臨床CRO治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。前臨床CRO治療の種類別市場規模（生物分析・DMPK研究、毒性試験、その他）、用途別市場規模（バイオ医薬品産業、政府・学術機関、医療機器産業）、地域別市場規模（北米、アメリ...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の前臨床CRO治療市場 2021：企業別、地域別、種類・用途別 The Preclinical CRO Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
世界の前臨床X線画像市場規模・現状・予測（2021年-2027年） An x-ray (radiograph) is a penetrating form of high-energy electromagnetic radiation and noninvasive medical test that helps physicians diagnose and treat medical conditions. Market Analysis and Insights: Global Preclinical X-ray Imaging Market The global Preclinical X-ray Imaging market size is pr…
世界の前臨床脳画像市場規模・現状・予測（2021年-2027年） Preclinical imaging is a technique used to monitor animals for research purposes such as in new drug development. Preclinical imaging includes many different imaging modalities, in which only few are suitable for imaging small animals, and others can be used in large animals. Market Analysis and Ins…
世界の磁気共鳴画像（MRI）市場規模・現状・予測（2021年-2027年） We can use magnetic resonance imaging (MRI) to provide 2- or 3-D images of the brain for the study of its anatomy, function, or molecular processes... or a combination of all three. The nice thing about MRI is that a researcher can chose whether the focus should be anatomical with a little bit of fu…
世界の陽電子放出断層撮影（PET）市場規模・現状・予測（2021年-2027年） PET creates three-dimensional (3D) images of a subject using radioactive tracers – molecules bound to a radioactive isotope – that are usually injected intravenously. The carrier molecule can bind to specific proteins, receptors, and biomolecular pathways in the body, to quantify a specific biologic…